Luis Ruilope Selected Research

Type 1 Angiotensin Receptor

1/2000

Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor Blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis Ruilope Research Topics

Disease

21	Hypertension (High Blood Pressure) 12/2023 - 01/2000
5	Heart Failure 04/2017 - 01/2000
4	Chronic Renal Insufficiency 01/2022 - 08/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 03/2002
2	Stroke (Strokes) 11/2022 - 01/2003
2	Inflammation (Inflammations) 01/2022 - 03/2002
2	Kidney Diseases (Kidney Disease) 12/2019 - 01/2017
2	Proteinuria 12/2019 - 01/2018
2	Albuminuria 01/2019 - 05/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2017 - 01/2017
1	Myocardial Infarction 11/2022
1	Disease Progression 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hyperkalemia 12/2019
1	Obstructive Sleep Apnea 01/2017
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 07/2015
1	Prediabetic State (Prediabetes) 07/2015
1	Glucose Intolerance 08/2013
1	Isolated Systolic Hypertension 01/2004
1	Coronary Disease (Coronary Heart Disease) 01/2003
1	Cough 01/2003
1	Vascular Remodeling 03/2002
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2000

Drug/Important Bio-Agent (IBA)

7	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 05/2002
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2000
3	Perindopril FDA LinkGeneric 02/2015 - 05/2003
2	Mineralocorticoid Receptor AntagonistsIBA 12/2019 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 12/2019 - 01/2019
2	AngiotensinsIBA 04/2017 - 01/2017
2	AldosteroneIBA 04/2017 - 01/2017
2	SodiumIBA 04/2017 - 01/2017
2	ReninIBA 04/2017 - 01/2017
2	Edetic Acid (EDTA)FDA Link 04/2017 - 01/2017
2	Erythropoietin FDA Link 04/2017 - 01/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2015 - 11/2014
2	aleglitazarIBA 07/2015 - 11/2014
2	olmesartanIBA 02/2015 - 12/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 02/2015 - 12/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2002 - 03/2002
1	salicylhydroxamic acid (SHAM)IBA 12/2023
1	antineoplaston A10 (A 10)IBA 11/2022
1	finerenoneIBA 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	CreatinineIBA 12/2019
1	PotassiumIBA 12/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	LipidsIBA 07/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2015
1	Insulin (Novolin)FDA Link 07/2015
1	Pioglitazone (Actos)FDA Link 11/2014
1	hydrochlorothiazide drug combination amilorideIBA 01/2004
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2004
1	Nifedipine (Adalat)FDA LinkGeneric 01/2004
1	DiureticsIBA 01/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2004
1	Indapamide FDA LinkGeneric 05/2003
1	Enalapril FDA LinkGeneric 05/2003
1	AlbuminsIBA 05/2003
1	perindopril drug combination indapamideIBA 05/2003
1	BradykininIBA 01/2003
1	Substance PIBA 01/2003
1	eprosartan (Teveten)FDA Link 01/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2002
1	Angiotensin IIIBA 03/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2002
1	Type 1 Angiotensin ReceptorIBA 01/2000

Therapy/Procedure

9	Denervation 12/2023 - 05/2012
7	Therapeutics 01/2020 - 01/2007
2	Peritoneal Dialysis 04/2017 - 01/2017
1	Renal Dialysis (Hemodialysis) 01/2017
1	Secondary Prevention 01/2017
1	Duration of Therapy 07/2015
1	Radiofrequency Ablation 08/2013
1	Catheters 05/2012